Skip to main content
Home

Top menu InfoLep

  • About InfoLep

Main navigation

  • Home
  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day 2022
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Antimicrobial resistance in leprosy
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [5]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
  • Publications
  • Organizations

Top menu - mobile infoLep

  • About InfoLep

Search

Refine your results

Refine your results


Selected filters

  • Reset filters
  • Western Pacific Region (WPR)
  • LRI / Leprosy Research Initiative
  • IDRI / Integration of rapid diagnostic tests to facilitate case management of leprosy (May 2015 - April 2019)

Filter by type

  • Publications only

NTD

  • Leprosy (Hansen disease) (9)
  • Chagas disease (American trypanosomiasis) (1)
  • Human African trypanosomiasis (HAT) - Sleeping sickness (1)
  • Leishmaniasis (1)
  • Lymphatic filariasis (Elephantiasis) (1)
  • Schistosomiasis (1)
  • Soil-transmitted helminths (1)
  • Trachoma (1)

Subject

  • Diagnostic tests (3)
  • Preventive Chemotherapy (PC) (1)
  • Delays in diagnosis (1)
  • Erythema nodosum leprosum - enl (Type 2 reaction) (1)
  • Complications and reactions (1)
  • Neglected tropical diseases (NTDs) (1)
  • Epidemiology (1)
  • Diagnosis (3)
  • Disability (1)
  • Stigma (1)
  • Stigma (leprosy related) (1)

Publication Type

  • Article (9)
  • Full text online (6)

Journal

  • Applied microbiology and biotechnology (1)
  • Development in practice (1)
  • Journal of immunology (Baltimore, Md. : 1950) (1)
  • Leprosy review (1)
  • PLoS neglected tropical diseases (2)
  • PLoS neglected tropical diseases (1)
  • Risk management and healthcare policy (1)
  • Scientific reports (1)

Year of Publication

  • 2018 (1)
  • 2016 (4)
  • 2015 (2)
  • 2013 (1)
  • 2012 (1)

Language

  • English (9)

Regional focus

  • African Region (AFR) (2)
    • Ethiopia (2)
  • European Region (EUR) (1)
    • United Kingdom (1)
  • Region of the Americas (AMR) (3)
    • Brazil (2)
  • South-East Asia Region (SEAR) (4)
    • Bangladesh (1)
    • India (1)
    • Indonesia (1)
  • (-) Western Pacific Region (WPR) (9)
    • China (1)
    • Japan (1)
    • Korea, South – Republic of Korea (1)
    • Philippines (5)

Research Group

  • EUR / Field evaluation of novel immunodiagnostic tools (Jan 2015- Dec 2018) (2)
  • IDEAL (2)
  • LSHTM / Development & validation severity scale ENL May 2015 - April 2017 (1)
  • LWM / Macro and micro epidemiology of leprosy in Cebu (1)
  • SARI Project (2010-2016) (1)
  • (-) LRI / Leprosy Research Initiative (9)
  • (-) IDRI / Integration of rapid diagnostic tests to facilitate case management of leprosy (May 2015 - April 2019) (3)
 
  • Relevance
  • Date
9 items

Publication

Evaluation of Immunodiagnostic Tests for Leprosy in Brazil, China and Ethiopia.

Hooij A, Kon Fat ET, da Silva M, et al. Scientific reports. 2018; 8 (1) : 17920.
Download PDF

Publication

Need for, and acceptability of, rapid diagnostic tests that can facilitate the diagnosis of leprosy.

Duthie M, Orcullo FM, Maghanoy AA, et al. Leprosy review. 2016; 87 (2) : 158-70.
Download PDF

Publication

Between-country inequalities in the neglected tropical disease burden in 1990 and 2010, with projections for 2020.

Stolk W, Kulik M, Le Rutte EA, et al. PLoS neglected tropical diseases. 2016; 10 (5) : e0004560.
Download PDF

Publication

Comparative evaluation of antibody detection tests to facilitate the diagnosis of multibacillary leprosy.

Duthie M, Orcullo FM, Abbelana J, et al. Applied microbiology and biotechnology. 2016;

Publication

Combination chemoprophylaxis and immunoprophylaxis in reducing the incidence of leprosy.

Duthie M, Balagon M. Risk management and healthcare policy. 2016;
Download PDF

Publication

Learning from a leprosy project in Indonesia: making mindsets explicit for stigma reduction.

Peters R, Lusli M, Zweekhorst MB, et al. Development in practice . 2015; 25 (8) : 1105 - 1119.

Publication

ENLIST 1: An international multi-centre cross-sectional study of the clinical features of erythema nodosum leprosum.

Walker SL, Balagon M, Darlong J, et al. PLoS neglected tropical diseases. 2015; 9 (9) : e0004065.
Download PDF

Publication

A retrospective study of the epidemiology of leprosy in Cebu: An eleven-year profile

Scheelbeek P, Balagon , Orcullo F, et al. PLoS neglected tropical diseases . 2013; 7 (9) : e2444.
Download PDF

Publication

New biomarkers with relevance to leprosy diagnosis applicable in areas hyperendemic for leprosy.

Geluk A, Bobosha K, Ploeg-van Schip JJ, et al. American Association of Immunologists. Journal of immunology (Baltimore, Md. : 1950). 2012; 188 (10) : 4782-91.
Download PDF

Use Ris for EndNote, Mendeley, RefWorks, Zotero and most other reference management software.

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications
  • Organizations

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2022 InfoNTD